LEAP THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.25 USD | +2.52% |
|
+16.07% | -21.59% |
Chart calendar Leap Therapeutics, Inc.
e9cf.wyqiJqmVDs0gGMdhMTAY4oSmYD_s3v4wsMtovKqYdRk.mVvhE5ise6JOKPACcFxas8noLme8n5ZeiKEB1uT5L12qYpp87606mnRvjg~acff08d9c521eef36086acc8b92add9a
Upcoming events on Leap Therapeutics, Inc.
Past events on Leap Therapeutics, Inc.
| 18/03/2024 11:00 | Q4 2023 Earnings Release |
| 23/01/2024 13:30 | Business Update Call |
| 20/01/2024 11:30 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 104 |
| 17/01/2024 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 10/01/2024 21:30 | JPMorgan Healthcare Conference |
| 28/11/2023 13:00 | Piper Sandler Healthcare Conference |
| 13/11/2023 12:00 | Q3 2023 Earnings Release |
| 13/09/2023 20:10 | Baird Global Healthcare Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 12:00 | Q2 2023 Earnings Release |
| 15/06/2023 | Annual General Meeting |
| 05/06/2023 17:30 | American Society of Clinical Oncology Conference - Abstract Number: 4027 |
| 15/05/2023 12:00 | Q1 2023 Earnings Release |
| 24/03/2023 11:00 | Q4 2022 Earnings Release |
| 15/03/2023 | Extraordinary Shareholders Meeting |
| 18/01/2023 18:30 | B. Riley Securities Oncology Conference |
| 17/01/2023 14:00 | Acquisition of Flame Biosciences, Inc. by Leap Therapeutics, Inc. Call |
| 29/11/2022 21:00 | Piper Sandler Healthcare Conference |
| 14/11/2022 12:00 | Q3 2022 Earnings Release |
| 10/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 553 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,50 1,70 -11.76% | 1,50 1,52 -1.63% | 0,00 1,20 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -33,5 -32,7 -2.32% | -28,5 -30,7 6.95% | -41,4 -43,0 3.62% | -56,8 -55,9 -1.62% | -87,0 -87,9 0.95% | -71,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,9 -32,5 -1.23% | -27,5 -35,4 22.37% | -40,6 -41,1 1.07% | -54,4 -55,2 1.33% | -81,4 -83,8 2.86% | -69,8 |
|
Net income Million USD | Released Forecast Spread | -33,3 -32,5 -2.33% | -37,6 -40,5 7.15% | -40,6 -41,1 1.13% | -54,6 -55,2 1.07% | -81,4 -83,8 2.86% | -69,8 |
|
EPS USD | Released Forecast Spread | -14,7 -14,2 -3.52% | -6,30 -6,40 1.56% | -4,70 -4,92 4.47% | -4,80 -4,88 1.64% | -3,98 -3,50 -13.71% | -2,25 |
| Announcement Date | 16/03/20 | 12/03/21 | 11/03/22 | 24/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,38 0,30 23.03% | 0,00 0,15 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 1,20 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,5 -12,0 12.9% | -10,6 -11,3 5.59% | -16,9 -11,0 -53.35% | -15,3 -13,3 -15.03% | -13,9 -13,0 -6.93% | -42,7 -14,4 -196.56% | -14,7 -14,2 -3.11% | -14,8 -15,2 2.1% | -14,8 -15,7 5.31% | -16,1 | -17,2 | -18,3 | -19,6 | -18,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,8 -11,3 3.9% | -10,4 -11,0 5.77% | -17,0 -10,9 -56.83% | -15,1 -13,2 -14.29% | -12,0 -12,8 6.87% | -41,9 -13,4 -211.67% | -13,4 -13,6 1.74% | -13,7 -14,2 3.37% | -12,5 -14,9 16.13% | -15,7 | -16,8 | -18,0 | -19,2 | -17,2 |
|
Net income Million USD | Released Forecast Spread | -10,8 -11,3 4.11% | -10,4 -11,0 5.77% | -17,0 -10,9 -56.83% | -15,1 -13,2 -14.29% | -12,1 -12,8 5.72% | -41,9 -13,4 -211.67% | -13,4 -13,6 1.74% | -13,7 -14,2 3.37% | -12,5 -14,9 16.13% | -15,7 | -16,8 | -18,0 | -19,2 | -17,2 |
|
EPS USD | Released Forecast Spread | -0,80 -1,10 27.27% | -0,90 -1,00 10% | -1,50 -0,96 -56.25% | -1,30 -1,18 -10.17% | -1,00 -1,10 9.09% | -3,20 -0,86 -272.09% | -0,91 -0,90 -1.56% | -0,51 -0,58 11.76% | -0,20 -0,56 63.96% | -0,59 | -0,62 | -0,62 | -0,49 | -0,40 |
| Announcement Date | 11/03/22 | 13/05/22 | 12/08/22 | 14/11/22 | 24/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 18/03/24 | - | - | - | - | - |
More events
Past sector events for Leap Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LPTX Stock
- Calendar Leap Therapeutics, Inc.
